Brief: Xortx Completes Positive Pre-Phase 3 Meeting With U.S. FDA
19/09/2022 12:17
Sept 19 (Reuters) - XORTX Therapeutics Inc XRTX.V :
* XORTX COMPLETES POSITIVE PRE-PHASE 3 MEETING WITH THE US
FOOD
AND DRUG ADMINISTRATION
* XORTX COMPLETES POSITIVE PRE-PHASE 3 MEETING WITH THE US
FOOD
AND DRUG ADMINISTRATION
Source text for Eikon: ID:nGNX8JFsfH
Further company coverage: XRTX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering